LFA-1 (CD11a/CD18) is a member of the β 2 -integrin family of adhesion molecules important in leukocyte trafficking and activation. Although LFA-1 is thought to contribute to the development of experimental autoimmune encephalomyelitis (EAE) primarily through its functions on effector T cells, its importance on other leukocyte populations remains unexplored. To address this question, we performed both adoptive transfer EAE experiments involving CD11a −/− mice and trafficking studies using bioluminescent T cells expressing luciferase under the control of a CD2 promoter (T-lux cells). Transfer of encephalitogenic CD11a −/− T cells to wild type mice resulted in a significant reduction in overall EAE severity compared to control transfers. We also observed, using in vivo imaging techniques, that CD11a −/− T-lux cells readily infiltrated lymph nodes and the CNS of wild type recipients with kinetics comparable to CD11a +/+ transfers, although their overall numbers in these organs were reduced. Surprisingly, transfer of encephalitogenic wild type T cells to CD11a −/− mice induced a severe and sometimes fatal EAE disease course, associated with massive T cell infiltration and proliferation in the CNS. These data indicate that LFA-1 expression on leukocytes in recipient mice plays an important immunomodulatory role in EAE. Thus, LFA-1 acts as a key regulatory adhesion molecule during the development of EAE, serving both proand anti-inflammatory roles in disease pathogenesis.
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Introduction
Multiple sclerosis (MS) is an inflammatory CNS disease in which leukocytes, including T cells, migrate into the CNS to initiate tissue destruction. These auto-reactive Tcells are activated outside the CNS and migrate across the blood brain barrier (BBB) into the CNS parenchyma through the use of a well-established adhesion cascade that utilizes members of several adhesion molecule families and their ligands (reviewed in Archelos et al., 1999; Engelhardt, 2006a; Engelhardt, 2006b; Ley et al., 2007; Luster et al., 2005) . In experimental autoimmune encephalomyelitis (EAE), the animal model for MS, VLA-4 and several members of the β 2 -integrin family of adhesion molecules have been implicated as key components required for trafficking across the BBB and thereby contributing to disease development (Bullard et al., 2007a; Bullard et al., 2005; Laschinger et al., 2002; Wang et al., 2007; Yednock et al., 1992) . The β 2 -integrin, LFA-1 (CD11a/CD18) is expressed on all leukocytes and has been extensively investigated in EAE and other MS model systems. However, the role of this adhesion molecule in EAE pathogenesis is controversial and conflicting results have been reported (Cannella et al., 1993; Gordon et al., 1995; Wang et al., 2007; Welsh et al., 1993; Willenborg et al., 1996) . For example, Welsh et al. (1993) found that treatment of mice with an anti-LFA-1 antibody resulted in a more severe inflammation and demyelination during EAE, while another study showed that CD11a −/− mice were significantly protected from disease (Wang et al., 2007) . Although some of these different findings may result from technical differences in the induction or evaluation of EAE, they may also indicate that LFA-1 serves both pro-and anti-inflammatory roles during the initiation and progression of CNS inflammatory events. In this report, we used both adoptive transfer and bioluminescent imaging techniques to further address the specific requirements for LFA-1 expression on both effector T cells and other leukocyte subsets during EAE development. We found that transfer of CD11a −/− MOG sensitized T cells to wild type recipients resulted in a significant, but incomplete attenuation of EAE, suggesting that LFA-1-independent adhesion mechanisms can also mediate effector T cell recruitment and activation. Surprisingly, the reciprocal transfer of wild type encephalitogenic T cells to CD11a 
